市场见解

Potential ASX winners from government’s $1.5bn manufacturing blueprint

The federal government is set to six key sectors that will shape Australia’s manufacturing future. These ASX stocks could be big winners.
The post Potential ASX winners from government’s $1.5bn manufacturing blueprint appeared first on Motley Fool Australia. –

multiple hands all reaching for winners' trophy representing stock winners

The federal government is set to announce a $1.5 billion plan and list six key sectors that will shape Australia’s manufacturing future.

The Australia Financial Review listed that the six priority areas that will receive the most government support. These are resources and critical minerals, food and beverages, medical products, recycling and clean energy, defence and space.

The $1.5 billion investment may not sound like much, but it’s only a start. The Morrison government is likely to provide further funding and other incentives to grow these sectors over the next decade.

This means there are a number of ASX stocks on the S&P/ASX 200 Index (Index:^AXJO) that could get a boost from the latest initiative.

ASX stocks in the winners’ circle

The plan was forged amid the COVID-19 economic firestorm. Prime Minister Scott Morrison defended picking these winners as he believes the Australia holds a competitive global advantage in these six key areas.

“The reality is we cannot and should not seek to reach global scale in a large number of sectors,” the AFR quoted the PM’s speech that will be delivered this afternoon.

“This is an important lesson from other small and medium-sized high-income economies which have leveraged home-grown manufacturing into global success, such as Singapore, the UK, Germany and Canada.”

Longer-term boost for these ASX shares

We are unlikely to see an immediate share price reaction to stocks that are well entrenched in the six priority sectors. But I believe they will see benefits starting to flow through over the coming months.

One stock that I think is set to rise with the manufacturing tide is the Austal Limited (ASX: ASB). This is one of my favourite stocks for FY21 and the manufacturing blueprint only reinforces my bullish view on the shipbuilder.

Importantly, Austal is also benefiting from US government stimulus as the Trump Administration looks to beef up its defence capabilities. Austal is getting both sides of its bread buttered.

ASX stock with high strategic value

Another stock that’s riding this wave is the Lynas Corporation Ltd (ASX: LYC) share price. I can’t help but feel the Morrison government is specifically singling out the rare earths miner under the “critical minerals” category.

The US and other Western countries are trying to break their dependence on China for the supply of these critical minerals. It’s hard to see how Lynas won’t play a part in this tectonic shift.

Biggest winners are at the smaller end

Biotech and medical device companies are another obvious ASX group in the manufacturing spotlight.

But before you get too excited about the CSL Limited (ASX: CSL) share price and Resmed CDI (ASX: RMD) share price, it’s the smaller players that will benefit more from government incentives.

In that respect, I think it’s stocks like Starpharma Holdings Limited (ASX: SPL) that will enjoy a more material uplift than the industry giants.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Brendon Lau owns shares of Austal Limited, CSL Ltd., and Lynas Limited. Connect with me on Twitter @brenlau.

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Austal Limited, CSL Ltd., and Starpharma Holdings Limited. The Motley Fool Australia has recommended ResMed Inc. and Starpharma Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Potential ASX winners from government’s $1.5bn manufacturing blueprint appeared first on Motley Fool Australia.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!